Osteoporosis: Bone-Formers

Teriparatide Superior to Risedronate in Reducing Fracture Risk in Older Women With Vertebral Fractures

By Chris Berrie...
dgnews.docguide.com

By Chris Berrie...
dgnews.docguide.com

FDA Approves Tymlos for Postmenopausal Osteoporosis

Radius Health, Inc., has announced that the US Food and Drug Administration (FDA) has approved Tymlos (abaloparatide) injection for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as history of osteoporotic fracture, multiple risk factors for fracture, or p...
mdedge.com

No Comments Yet.

Leave a comment